| 3624- | Cro, | Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment |
| - | Review, | AD, | NA |
| 3625- | Cro, | Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial |
| - | Trial, | AD, | NA |
| 3626- | Cro, | Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial |
| - | Trial, | AD, | NA |
| 3627- | Cro, | The effects of Crocus sativus (saffron) and its constituents on nervous system: A review |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3628- | Cro, | VitE, | CUR, | Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 3629- | Cro, | Studying saffron nanopowder (Crocus Sativus L.) on the temporal memory of rats suffering Parkinson's disease |
| - | in-vivo, | Park, | NA |
| 3630- | Cro, | Crocin Improves Cognitive Behavior in Rats with Alzheimer's Disease by Regulating Endoplasmic Reticulum Stress and Apoptosis |
| - | in-vivo, | AD, | NA |
| 3631- | Cro, | Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease |
| - | in-vitro, | AD, | HT22 | - | in-vivo, | AD, | NA |
| 3634- | Cro, | A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease |
| - | Trial, | AD, | NA |
| 3635- | Cro, | A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures |
| - | Review, | NA, | NA |
| 3637- | Cro, | Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment |
| - | NA, | AD, | NA |
| 3832- | Cro, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4158- | Cro, | Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus |
| - | in-vivo, | AD, | NA |
| 945- | Cro, | Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Cerv, | HeLa |
| 6522- | CRV, | l-carvone decreases breast cancer cells adhesion, migration, and invasion by suppressing FAK activation |
| - | in-vivo, | Var, | NA |
| 6521- | CRV, | L-carvone induces p53, caspase 3 mediated apoptosis and inhibits the migration of breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 6527- | CRV, | Preventive effect of D-carvone during DMBA induced mouse skin tumorigenesis by modulating xenobiotic metabolism and induction of apoptotic events |
| - | in-vivo, | Melanoma, | NA |
| 6520- | CRV, | Health Benefits and Pharmacological Properties of Carvone |
| - | Review, | Nor, | NA |
| 6523- | CRV, | Anticancer effects of Carvone in myeloma cells is mediated through the inhibition of p38 MAPK signalling pathway, apoptosis induction and inhibition of cell invasion |
| - | NA, | Melanoma, | NA |
| 6524- | CRV, | d-Carvone inhibits the JAK/STAT3 signaling pathway and induced the apoptotic cell death in the human gastric cancer AGS cells |
| - | in-vitro, | GC, | AGS |
| 6525- | CRV, | D-carvone induced ROS mediated apoptotic cell death in human leukemic cell lines (Molt-4) |
| - | in-vitro, | AML, | NA |
| 6526- | CRV, | Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based study |
| - | Review, | NSCLC, | NA |
| 6528- | CRV, | D-carvone inhibits growth, migration, cell cycle at G0/G1 phase and induces apoptosis in A431 cells by disrupting mitochondrial membrane potential |
| - | in-vitro, | Melanoma, | A431 |
| 6533- | CRV, | Potential anticancer activity of carvone in N2a neuroblastoma cell line |
| - | in-vitro, | neuroblastoma, | N9 |
| 6532- | CRV, | doxoR, | R-(-)-carvone Attenuated Doxorubicin Induced Cardiotoxicity In Vivo and Potentiated Its Anticancer Toxicity In Vitro |
| - | in-vivo, | BC, | MCF7 | - | in-vivo, | Nor, | H9c2 |
| 6531- | CRV, | D-carvone attenuates LPS-induced acute lung injury via TLR4/NF-κB and Nrf2/HO-1 signaling pathways in rats |
| - | in-vivo, | Nor, | NA |
| 6530- | CRV, | Monoterpenes as Anticancer Therapeutic Agents |
| - | Review, | Var, | NA |
| 6529- | CRV, | D-Carvone Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting Oxidative Stress and TGF-ß 1/SMAD3 Signaling Pathway |
| - | in-vivo, | Nor, | NA |
| 7421- | CS, | Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial |
| - | Trial, | Nor, | NA |
| 7417- | CS, | CGA, | Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans |
| - | Trial, | Nor, | NA |
| - | Study, | Nor, | NA |
| 7419- | CS, | Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial |
| - | Trial, | Nor, | NA |
| - | Trial, | Obesity, | NA |
| 7425- | CS, | Artichoke as a melanoma growth inhibitor |
| - | in-vitro, | Melanoma, | NA |
| 7416- | CS, | Poly, | Phenolic-Rich Extracts from Artichoke By-Products Promote Apoptosis in Human Colorectal Cancer Cell Lines |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Colon, | HT29 |
| 7415- | CS, | Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells |
| - | in-vitro, | AML, | THP1 |
| 7414- | CS, | Pro-Apoptotic Activity of Artichoke Leaf Extracts in Human HT-29 and RKO Colon Cancer Cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | RKO |
| 7413- | CS, | Poly, | Anticancer effects induced by artichoke extract in oral squamous carcinoma cell lines |
| - | in-vitro, | SCC, | SCC25 |
| 7412- | CS, | Chemo, | Artichoke Polyphenols Sensitize Human Breast Cancer Cells to Chemotherapeutic Drugs via a ROS-Mediated Downregulation of Flap Endonuclease 1 |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 7411- | CS, | Long Term Exposure to Polyphenols of Artichoke (Cynara scolymus L.) Exerts Induction of Senescence Driven Growth Arrest in the MDA-MB231 Human Breast Cancer Cell Line |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | CRC, | HCT116 |
| 7410- | CS, | Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231 |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7423- | CS, | Prophylactic effects of Cynara scolymus L. leaf and flower hydroethanolic extracts against diethylnitrosamine/acetylaminoflourene-induced lung cancer in Wistar rats |
| - | in-vivo, | Nor, | NA |
| 7424- | CS, | CGA, | Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells |
| - | in-vitro, | Nor, | NA | - | in-vitro, | Liver, | HepG2 |
| 7427- | CS, | Poly, | Polyphenols from artichoke heads (Cynara cardunculus (L.) subsp. scolymus Hayek): in vitro bio-accessibility, intestinal uptake and bioavailability |
| - | Study, | Nor, | NA |
| 7428- | CS, | Exploring the Cardiovascular Potential of Artichoke—A Comprehensive Review |
| - | Review, | Nor, | NA |
| 7429- | CS, | Functional and Therapeutic Potential of Cynara scolymus in Health Benefits |
| - | Review, | Nor, | NA | - | Review, | IBD, | NA | - | Review, | AD, | NA |
| 7422- | CS, | Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis |
| - | Review, | Nor, | NA |
| 1601- | Cu, | The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress |
| - | in-vitro, | CRC, | NA |
| 1642- | Cu, | HCAs, | Copper-assisted anticancer activity of hydroxycinnamic acid terpyridine conjugates on triple-negative breast cancer |
| - | in-vitro, | BC, | 4T1 | - | in-vitro, | Nor, | L929 |
| 1639- | Cu, | HCAs, | Green synthesis of copper oxide nanoparticles using sinapic acid: an underpinning step towards antiangiogenic therapy for breast cancer |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid